ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2025
Success of Apheresis Platelet Replacement in Patients With Antiaggregant Drug-Associated Epistaxis and Cost Effectiveness Analysis.
Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to prevent surgical complications and reduce costs in epistaxis patients using antiplatelet drugs. While emphasizing the importance of apheresis platelet, which is an option as effective as surgery, we aim to highlight this treatment, which has become a medical taboo due to the risk of thrombosis, although there is no clear opinion in the guidelines. We aimed to overcome this situation by creating an algorithm. This study on epistaxis patients using antiplatelet drugs was conducted retrospectively at a university medical faculty hospital. A treatment algorithm was created to avoid surgery and reduce costs. The opinions of the departments where consultation was requested played a role in dividing the patients into groups. Group 1 patients consisted of patients who underwent platelet apheresis (PA) replacement after departmental consultations for epistaxis control. Group 2 patients consisted of patients who underwent surgical treatment for epistaxis control. The mean cost (Turkish Liras/Currency) of Group 1 patients (2486.6 ± 567, 1750-4000) was statistically significant less as compared to the group 2 patients (5673.8 ± 1982.5, 4000-12000). ( Supplementary Information: The online version contains supplementary material available at 10.1007/s12070-025-05399-3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.